MiniMedvsThermo Fisher Scientific

MMED and TMO stock compared: price, dividend, valuation and results, from SEC filings.

MMED

MiniMed Group, Inc.

$17.78

Value $5.0B

-4.66%
MMED's page

TMO

Thermo Fisher Scientific Inc

$686.79

Value $255B

-0.66%
TMO's page

MiniMed (MMED) has a market value of $5.0B and Thermo Fisher Scientific (TMO) $255B. Dividend yield: MMED none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MMED$5.0B

    TMO$255B

    TMO is 51 times MMED

  • Revenue, 12 months

    MMED$3.2B

    TMO$47.4B

    TMO is 15 times MMED

  • Net income, 12 months

    MMED-$314M

    TMO$7.1B

  • Operating margin

    MMED-5.3%

    TMO17.9%

    23.2 points apart

  • ROIC

    MMED-3.8%

    TMO8.2%

    12.0 points apart

  • P/E

    MMED–

    TMO36.1

  • Dividend yield

    MMED0.0%

    TMO0.3%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MMED-3.8%

TMO+37.2%

75100125

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MMEDMiniMedTMOThermo Fisher Scientific

Valuation

MMEDTMO
Valuation
Price$17.78$686.79
Market value$5.0B$255B
Enterprise value (EV)$4.8B$290B
P/E–36.1
P/E, 5-year median–32.7
P/B1.44.7
EV/EBIT–34.3
Free cash flow yield–3.0%

Results and growth

MMEDTMO
Results and growth
Revenue, 12 months$3.2B$47.4B
Net income, 12 months-$314M$7.1B
Free cash flow, 12 months-$316M$7.6B
Earnings per share, 12 months-$1.12$18.96
Revenue growth, year on year14.2%3.9%
Revenue growth a year, past+12.1%over 2 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

MMEDTMO
Margins and returns on capital
Gross margin53.9%–
Operating margin-5.3%17.9%
Net margin-9.8%14.9%
ROIC-3.8%8.2%
ROE-8.8%13.4%

Balance sheet

MMEDTMO
Balance sheet
Cash$207M$6.1B
Total debt$59M$41.4B
Net debt / EBITDA–3.7
Interest cover–5.5×

Dividends and buybacks

MMEDTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MMED or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, MiniMed or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($255B) is about 51.1 times MiniMed ($5.0B), at today's prices.

Which pays the higher dividend, MMED or TMO?

The dividend yield at today's price is none for MiniMed and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, MiniMed or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -9.8% for MiniMed and 14.9% for Thermo Fisher Scientific, and the operating margin -5.3% and 17.9%. Revenue was $3.2B and $47.4B.

Which is the better investment, MiniMed or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.